We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdvaMed Suggests FDA Exclude Devices from Patient-Focused Development Guidance
AdvaMed Suggests FDA Exclude Devices from Patient-Focused Development Guidance
In comments on the third installment of the FDA’s draft guidance on patient-focused drug development, AdvaMed has recommended that the guidance not apply to medical devices — although the industry association says it supports the overall use of patient experience measures as clinical trial endpoints.